What to Expect
Attendees
Be part of over 400 professionals at the 7th Vaccine World Asia Congress 2025 – South East Asia & RNA Therapeutics & Manufacturing Asia! This is your opportunity to connect with industry leaders, broaden your network, and participate in impactful discussions that will define the future of vaccines and RNA therapeutics.
Companies
Connect with 150 leading companies shaping the future of the vaccines and RNA sector. Whether you're seeking new partnerships or exploring cutting-edge breakthroughs, this is the ideal platform to discover the next wave of innovation in the industry.
Speakers
Gain exclusive insights from 60 leading experts who are shaping the future of vaccines and RNA therapeutics. Learn from the foremost authorities in the field as they share innovative knowledge, practical solutions, and emerging trends that you won’t want to miss.
Concept
The 7th Vaccine World Asia Congress 2025 – Southeast Asia and RNA Therapeutics and Manufacturing Asia 2025 will take place in Bangkok, Thailand, on November 5-6, 2025, providing an unparalleled platform for professionals from the vaccine and RNA therapeutic sectors to come together.
Vaccine World Asia Congress 2025 – Southeast Asia will address the robust growth expected in the Southeast Asian vaccine market in 2025, driven by increasing demand for immunization programs, rising healthcare awareness, and ongoing efforts to strengthen public health systems. As regional governments prioritize vaccination campaigns to combat infectious diseases like COVID-19 variants, influenza, and emerging threats such as dengue and respiratory infections, the event will focus on expanding immunization coverage in underserved areas, advancing universal vaccines, strengthening local manufacturing capabilities, accelerating research, and integrating innovative technologies to reshape vaccine development throughout Southeast Asia.
In parallel, RNA Therapeutics and Manufacturing Asia 2025 will delve into the burgeoning RNA therapeutic market in Asia, which is projected to grow at a CAGR of 15.6% from 2021 to 2027. This growth is driven by government funding, strategic partnerships, and the high prevalence of infectious diseases. With RNA therapeutics offering precise treatments targeting diseases at the molecular level, the conference will explore key trends in mRNA, RNA interference (RNAi), antisense oligonucleotides, and scalable manufacturing solutions. Discussions will also focus on optimizing RNA synthesis, purification, and quality control, while exploring cost-effective, high-yield production technologies. Given Asia’s emerging role as a hub for RNA innovation, this event will bring together experts, researchers, and industry leaders to share insights, tackle challenges, and drive the future of RNA-based therapies.
These two co-located conferences will provide a unique opportunity for cross-sector collaboration, enabling delegates to explore synergies between vaccine development and RNA-based therapeutic innovation, and further strengthen Southeast Asia’s position as a leader in both fields.
What's New in 2025?
Launching RNA Therapeutics & Manufacturing with VWSEA: This event will showcase the convergence of groundbreaking RNA-based therapies and vaccine innovations, driving forward advancements that promise to enhance global health solutions.
Strategic Industry Positioning: Southeast Asia has emerged as a key hub for vaccine manufacturing and R&D, with RNA technologies playing an increasingly pivotal role. This joint event positions the region at the forefront of global RNA innovation and manufacturing, emphasizing its growing importance in advancing global health.
Increased Attendee Numbers & Company Representation: By bringing together leaders from both RNA therapeutics and vaccine development, this event offers attendees the chance to network across complementary fields, fostering partnerships, collaborations, and knowledge exchange.
Innovative Event Format & Structure: This year’s event introduces an innovative format, featuring dedicated sessions on Regulatory Insights that provide a comprehensive overview of the regulatory landscape influencing RNA therapeutics and vaccine manufacturing in Asia. A C-Suite Think Tank will also be introduced, allowing industry executives and leaders to engage in high-level discussions on the future of RNA-based therapies and vaccines.
Ministry Opening Remarks: To highlight the growing importance of the biopharma sector, we have included opening remarks from government ministries, offering key insights into policies, investment, and government support aimed at fostering innovation in the sector.
The Only Event in Asia Focusing on Both Vaccines and RNA Under One Roof.
WHO
The Vaccine World Asia Congress 2025 - SEA, alongside RNA Therapeutics and Manufacturing Asia, is the premier event for professionals involved in the rapidly evolving fields of vaccine development and RNA therapeutics. This congress brings together thought leaders, innovators, and key stakeholders shaping the future of global health solutions. The event is designed for individuals from various sectors, including:
▶ Biopharma Executives and Researchers
- Senior leaders and decision-makers from vaccine manufacturers, biotech companies, and pharmaceutical companies focusing on RNA-based therapies.
- Researchers and scientists working in vaccine development, RNA technologies, and related fields, eager to stay updated on emerging trends and regulatory shifts.
▶ Regulatory and Compliance Professionals
- Experts in vaccine regulatory affairs, drug safety, and quality assurance seeking insights into the regulatory landscape for RNA therapeutics and vaccine manufacturing in Asia.
- Policy advisors and government officials looking to understand industry trends and contribute to advancing regulatory frameworks.
▶ C-suite Executives
- CEOs, COOs, CSOs, and other C-suite leaders aiming to discuss and shape the strategic direction of their organizations in the evolving RNA and vaccine markets.
- Executives focused on investment strategies, R&D leadership, and global health initiatives, looking for new opportunities and partnerships in the biopharma sector.
▶ Public Health Experts
- Global health organizations and non-governmental organizations (NGOs) focused on improving vaccine access, delivery, and public health infrastructure.
▶ Supply Chain and Manufacturing Leaders
- Operations and supply chain executives responsible for the manufacturing, distribution, and delivery of vaccines and RNA-based therapies.
- Facility managers and production leaders interested in optimizing vaccine and RNA manufacturing processes and improving operational efficiency.
▶ Technology and Innovation Specialists
- Professionals working in AI, data science, and digital health who are exploring how emerging technologies can optimize RNA and vaccine development.
- Engineers, IT specialists, and digital transformation leaders looking to advance manufacturing capabilities and regulatory compliance using cutting-edge technologies.
▶ Academia and Research Institutions
- Professors, researchers, and students from academic and research institutions dedicated to exploring the latest breakthroughs in vaccine development and RNA therapeutics.
- Universities and research centers collaborating on projects related to RNA vaccines, gene therapies, and next-generation medical solutions.
WHAT
The Vaccine World Asia Congress 2025 - SEA and RNA Therapeutics and Manufacturing Asia bring together industry leaders, innovators, and policy makers to explore the latest advancements in vaccine development and RNA therapeutics. Here’s what to expect:
▶ Cutting-Edge Sessions & Insights:
Access exclusive sessions with 60+ expert speakers sharing the latest trends and breakthroughs in vaccine and RNA therapeutics.
▶ Industry Innovations & Technologies:
Discover breakthrough innovations in vaccine manufacturing, RNA technologies, and therapeutic applications shaping global health.
▶ Regulatory Insights:
Stay ahead with sessions on evolving regulatory landscapes in Asia for vaccines and RNA therapeutics.
▶ C-Suite Think Tanks:
Engage in high-level discussions on the strategic direction of RNA therapies and vaccines with industry executives.
▶ Government & Policy Perspectives:
Hear from policy makers about healthcare initiatives and government-backed support for biopharma innovations.
▶ SEA & Asia as a Biopharma Hub:
Explore SEA and Asia’s growing role in vaccine and RNA therapeutics innovation and its global impact.
▶ Unique in Asia:
This is the only event in Asia uniting both vaccine and RNA therapeutics discussions under one roof.
WHY
The Vaccine World Asia Congress 2025 - SEA and RNA Therapeutics and Manufacturing Asia are two of the most anticipated events of the year, bringing together top experts, innovators, and industry leaders to explore the latest breakthroughs and trends in vaccine development and RNA-based therapeutics. Here's why you shouldn't miss it:
Strategic Networking Opportunities
As the only event in Asia combining both vaccine and RNA therapeutic tracks, connect with key players, build partnerships, and explore collaborative opportunities to drive innovation in both sectors.
Focused Sessions on Regulatory Insights and Future Trends
Gain in-depth knowledge on regulatory challenges and emerging trends shaping the future of vaccines and RNA therapeutics, led by industry experts.
Ministry and Government Support
Hear from regional ministries on government support, policy development, and investment initiatives driving biopharma innovation in Southeast Asia.
Discover Southeast Asia’s Leadership in Biopharma
Explore Southeast Asia’s growing role as a global leader in vaccine manufacturing and RNA therapeutics research and development.
Innovative Event Format
Enjoy a dynamic event format with interactive sessions, C-suite think tanks, and roundtable discussions designed for deeper engagement and actionable insights.
Be Part of the Future of Global Health
Join critical discussions shaping the future of vaccines and RNA therapeutics. Your participation is key to staying ahead in this rapidly advancing field.
Contact
Share With Your Network
